Race and Ethnicity: A Part of the Equation for Personalized Clinical Decision Making?
作者信息
Paulus Jessica K, Kent David M
机构信息
From the Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center/Tufts University School of Medicine, Boston, MA.
出版信息
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). doi: 10.1161/CIRCOUTCOMES.117.003823.
Abstract
摘要
相似文献
1
Race and Ethnicity: A Part of the Equation for Personalized Clinical Decision Making?
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). doi: 10.1161/CIRCOUTCOMES.117.003823.
2
Racial/ethnic health disparities in cardiovascular disease during the COVID-19 pandemic: revisiting a long-lasting problem.
Cardiovasc Res. 2022 Jan 7;118(1):e8-e10. doi: 10.1093/cvr/cvab318.
3
Contemporary concepts in access to healthcare: Identification and elimination of disparities in care of minority patients.
Prog Cardiovasc Dis. 2020 Jan-Feb;63(1):2-3. doi: 10.1016/j.pcad.2019.12.003. Epub 2019 Dec 6.
4
Precision Medicine and Personalized Medicine in Cardiovascular Disease.
Adv Exp Med Biol. 2018;1065:589-605. doi: 10.1007/978-3-319-77932-4_36.
5
The social, economic, political, and genetic value of race and ethnicity in 2020.
Hum Genomics. 2020 Oct 15;14(1):37. doi: 10.1186/s40246-020-00284-2.
6
Editorial: The Complexity of Reporting Race and Ethnicity in Orthopaedic Research.
Clin Orthop Relat Res. 2018 May;476(5):917-920. doi: 10.1007/s11999.0000000000000259.
7
Genetics of cardiovascular disease: Importance of sex and ethnicity.
Atherosclerosis. 2015 Jul;241(1):219-28. doi: 10.1016/j.atherosclerosis.2015.03.021. Epub 2015 Mar 16.
8
Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.
Prog Cardiovasc Dis. 2020 Mar-Apr;63(2):142-148. doi: 10.1016/j.pcad.2020.02.006. Epub 2020 Feb 11.
9
Emerging Concepts in Precision Medicine and Cardiovascular Diseases in Racial and Ethnic Minority Populations.
Circ Res. 2019 Jun 21;125(1):7-13. doi: 10.1161/CIRCRESAHA.119.314970. Epub 2019 Jun 20.
10
Future Physicians in the Era of Precision Cardiovascular Medicine.
Circulation. 2017 Oct 24;136(17):1572-1574. doi: 10.1161/CIRCULATIONAHA.117.029676.
引用本文的文献
1
A practical framework for appropriate implementation and review of artificial intelligence (FAIR-AI) in healthcare.
NPJ Digit Med. 2025 Aug 11;8(1):514. doi: 10.1038/s41746-025-01900-y.
2
Fairness of machine learning readmission predictions following open ventral hernia repair.
Surg Endosc. 2025 Jul 7. doi: 10.1007/s00464-025-11927-7.
3
Development of Explainable Machine Learning Models to Identify Patients at Risk for 1-Year Mortality and New Distant Metastases Postendoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Secondary Analysis of the PARITY Trial.
JB JS Open Access. 2025 May 22;10(2). doi: 10.2106/JBJS.OA.24.00213. eCollection 2025 Apr-Jun.
4
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk.
Diabetologia. 2025 Jun;68(6):1157-1168. doi: 10.1007/s00125-025-06379-6. Epub 2025 Mar 12.
5
Reporting of Fairness Metrics in Clinical Risk Prediction Models Used for Precision Health: Scoping Review.
Online J Public Health Inform. 2025 Mar 19;17:e66598. doi: 10.2196/66598.
6
Enhancing Clinical Decision Support in Nephrology: Addressing Algorithmic Bias Through Artificial Intelligence Governance.
Am J Kidney Dis. 2024 Dec;84(6):780-786. doi: 10.1053/j.ajkd.2024.04.008. Epub 2024 Jun 6.
7
Defining a Minimal Benchmark for Cardiovascular Risk Prediction Calculators in New England Electronic Health Record-Derived Cohort.
Circ Cardiovasc Qual Outcomes. 2024 Jun;17(6):e010439. doi: 10.1161/CIRCOUTCOMES.123.010439. Epub 2024 May 30.
8
Considerations for using predictive models that include race as an input variable: The case study of lung cancer screening.
J Biomed Inform. 2023 Nov;147:104525. doi: 10.1016/j.jbi.2023.104525. Epub 2023 Oct 14.
9
Using measures of race to make clinical predictions: Decision making, patient health, and fairness.
Proc Natl Acad Sci U S A. 2023 Aug 29;120(35):e2303370120. doi: 10.1073/pnas.2303370120. Epub 2023 Aug 22.
10
A machine learning evaluation of patient characteristics associated with prescribing of guideline-directed medical therapy for heart failure.
Front Cardiovasc Med. 2023 Jun 21;10:1169574. doi: 10.3389/fcvm.2023.1169574. eCollection 2023.
本文引用的文献
1
SCIENCE AND SOCIETY. Taking race out of human genetics.
Science. 2016 Feb 5;351(6273):564-5. doi: 10.1126/science.aac4951.
2
All else being equal, men and women are still not the same: using risk models to understand gender disparities in care.
Circ Cardiovasc Qual Outcomes. 2015 May;8(3):317-20. doi: 10.1161/CIRCOUTCOMES.115.001842. Epub 2015 Apr 21.
3
On the causal interpretation of race in regressions adjusting for confounding and mediating variables.
Epidemiology. 2014 Jul;25(4):473-84. doi: 10.1097/EDE.0000000000000105.
4
Will value-based purchasing increase disparities in care?
N Engl J Med. 2013 Dec 26;369(26):2472-4. doi: 10.1056/NEJMp1312654.
5
Commentary: considerations for use of racial/ethnic classification in etiologic research.
Am J Epidemiol. 2001 Aug 15;154(4):291-8. doi: 10.1093/aje/154.4.291.
6
Decision analysis.
N Engl J Med. 1987 Jan 29;316(5):250-8. doi: 10.1056/NEJM198701293160505.
Zotero 插件